| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.01B | 28.24B | 34.76B | 31.06B | 26.97B | 19.36B |
| Gross Profit | 5.46B | 4.29B | 5.89B | 5.61B | 4.10B | 3.07B |
| EBITDA | 2.53B | 2.08B | 3.47B | 2.72B | 1.43B | 1.12B |
| Net Income | 1.89B | 1.27B | 2.64B | 2.16B | 1.37B | 957.39M |
Balance Sheet | ||||||
| Total Assets | 30.34B | 24.62B | 25.66B | 24.95B | 19.41B | 16.02B |
| Cash, Cash Equivalents and Short-Term Investments | 13.40B | 10.42B | 11.51B | 11.01B | 10.03B | 7.88B |
| Total Debt | 3.28B | 1.59B | 985.93M | 1.91B | 525.97M | 174.18M |
| Total Liabilities | 21.15B | 15.86B | 17.26B | 18.31B | 14.90B | 12.41B |
| Stockholders Equity | 9.18B | 8.76B | 8.40B | 6.64B | 4.50B | 3.59B |
Cash Flow | ||||||
| Free Cash Flow | 4.49B | -1.20B | 2.24B | 2.43B | 2.74B | 1.65B |
| Operating Cash Flow | 5.72B | 298.92M | 3.58B | 3.08B | 3.69B | 2.22B |
| Investing Cash Flow | -5.20B | 92.55M | -430.31M | -2.06B | -824.32M | -1.04B |
| Financing Cash Flow | 271.76M | -465.48M | -2.04B | -379.39M | -207.44M | -358.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$258.31B | 9.90 | 18.03% | 1.95% | ― | ― | |
72 Outperform | HK$5.29B | 6.43 | 10.46% | 1.19% | 8.84% | 13.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$37.84B | 5.28 | 21.04% | 1.83% | 2.41% | -25.60% | |
60 Neutral | HK$75.36B | 115.71 | -4.91% | ― | 139.96% | 86.04% | |
53 Neutral | HK$135.18B | -122.26 | -9.33% | ― | 86.21% | 51.50% | |
47 Neutral | HK$70.50B | -4.42 | -7.98% | 1.35% | -8.79% | -212.16% |